Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 12
Submit an article Journal homepage
391
Views
7
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Differences in hematological and non-hematological toxicity during treatment with imatinib in patients with early and late chronic phase chronic myeloid leukemia

Massimo Breccia Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, ItalyCorrespondence[email protected]
, MD,
Caterina Stefanizzi Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy
,
Laura Cannella Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy
,
Roberto Latagliata Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy
,
Anna Maria Frustaci Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy
,
Ida Carmosino Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy
,
Michelina Santopietro Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy
&
Giuliana Alimena Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy
 show all
Pages 2328-2332 | Received 09 Jul 2008, Accepted 24 Oct 2008, Published online: 01 Jul 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jing Ni, Jian Hong, Zhendong Zhang, Qingsheng Li, Ruixiang Xia, Qingshu Zeng & Guoping Sun. (2020) Marrow fibrosis is an independent predictor of hematological toxicity of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. Leukemia & Lymphoma 61:5, pages 1195-1200.
Read now
Hanna J. Khoury & Dale L. Bixby. (2015) Outcomes of chronic-phase chronic myeloid leukemia beyond first-line therapy. Leukemia & Lymphoma 56:3, pages 568-576.
Read now

Articles from other publishers (5)

Lando Janssen, Neeltje A. E. Allard, Christiaan G. J. Saris, Jaap Keijer, Maria T. E. Hopman & Silvie Timmers. (2020) Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology. Physiological Reviews 100:2, pages 633-672.
Crossref
B.M.E. Tullemans, J.W.M. Heemskerk & M.J.E. Kuijpers. (2018) Acquired platelet antagonism: off‐target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors. Journal of Thrombosis and Haemostasis 16:9, pages 1686-1699.
Crossref
Sociedade Brasileira de Patologia & Sociedade Brasileira de Pediatria. (2013) Leucemia mieloide crônica. Revista da Associação Médica Brasileira 59:3, pages 220-232.
Crossref
Nicholas A. Barber, Wais Afzal & Mojtaba Akhtari. (2011) Hematologic toxicities of small molecule tyrosine kinase inhibitors. Targeted Oncology 6:4, pages 203-215.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.